Trial Details
WITHDRAWNBasic Information
| Clinical ID | c3714 |
|---|---|
| Identifier | NCT01635621 |
| Trial Title | A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Olokizumab (OKZ)|DRUG: Placebo |
Participant Information
| Sponsor | UCB BIOSCIENCES GmbH |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2012-06 |
|---|---|
| Primary Completion Date | 2013-08 |
| Completion Date | 2013-08 |